📰 Illinois Based Baxter News
Illinois Based Baxter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Illinois Based Baxter. Real-time updates on events, politics, business and more.
December 1, 2023
Baxter (NYSE:BAX) issued an urgent medical device correction notice regarding its Novum IQ syringe infusion pump.
November 16, 2023
The FDA determined that the recall of the Baxter (NYSE:BAX) Novum IQ syringe pump is Class 1, the most serious kind.
October 16, 2023
Baxter (NYSE:BAX) announced today that it launched a digital image capture capability for eye exams using its existing opthalmoscope.
June 29, 2023
Baxter [WtwhTicker symbol="BAX"](NYSE: BAX)[/WtwhTicker] announced today that it launched its new intensive care unit bed.
April 24, 2023
Baxter reported higher pay for three other executives and a big incentive to bring on a new hire last year.
August 31, 2022
Baxter (NYSE:BAX) announced today that the FDA issued 510(k) clearance to its Novum IQ infusion pump with Dose IQ safety software.
August 25, 2022
Baxter (NYSE:BAX) announced that it expanded its partnership with The Links to improve awareness and resources related to kidney health.
May 25, 2022
Baxter (NYSE:BAX) today issued long-term financial guidance that projects growth over the next three years.
April 19, 2022
Baxter announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes.
April 5, 2022
Baxter (NYSE:BAX) announced today that it received FDA 510(k) clearance for its ST Set in continuous renal replacement therapy (CRRT).